To receive continuing education (CE) credit, you must complete the virtual lecture, CE posttest and activity evaluation.
CE Credit Available Until: July 19, 2019
To provide a learning opportunity for oncology nurses, social workers and other healthcare professionals to expand their knowledge of treating patients with acute myeloid leukemia (AML).
This activity has been designed to meet the educational needs of nurse practitioners, nurses and oncology social workers at intermediate and advanced levels of practice, caring for patients with hematologic malignancies.
At the conclusion of this program, participants will be able to:
- Describe the role of genomics and other testing in diagnostic and treatment approaches for AML
- Identify standard of care and new treatment approaches, including Beat AML® and other clinical trials for AML
- Understand the central role of the HCP in assessment, monitoring for, and managing side effects of treatments
- Provide resources for support of the patient and family throughout the treatment process
James M. Foran, MD, FRCPC
Associate Professor and Chair
Acute Leukemia & Myeloid Neoplasm Disease Group
Mayo Clinic Cancer Center
Associate Chair of Medicine [Research]
Mayo Clinic Florida
Leukemia & Bone Marrow
Margaret Green, RN, OCN®
Research Nurse Associate
Department of Medicine
Section of Hematology/Oncology
University of Chicago Medicine and Biological Sciences
Darci L. Zblewski, APRN, C-NP, OCN®
Supervisor, APP Group
Division of Hematology
This activity is supported by The Leukemia & Lymphoma Society.